{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:45:38Z","timestamp":1792601138987,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009074","name":"Huai'an University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007924","name":"Bengbu Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Department of Education of Anhui Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119428","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:47:18Z","timestamp":1791992838000},"page":"119428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Antitumor EF24 analogue-integrated platinum (IV) prodrugs induce autophagy-mediated immunogenic cell death and PD-L1 downregulation in colorectal cancer"],"prefix":"10.1016","volume":"321","author":[{"given":"Qingqing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119428_bib1","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1021\/acs.jmedchem.5c03745","article-title":"Preclinical evaluation of 5T4-targeted [89Zr]Zr-DFO-HB5 immuno-PET imaging and comparison of 161Tb vs 177LT radionuclide therapy for colorectal cancer","volume":"69","author":"Liang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jnci\/djab127","article-title":"Early-onset colorectal cancer: the mystery remains","volume":"113","author":"Eng","year":"2021","journal-title":"JNCI, J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2026.119428_bib3","doi-asserted-by":"crossref","first-page":"22333","DOI":"10.1021\/acs.jmedchem.5c01224","article-title":"Synthesis and preclinical evaluation of DDR1-Targeted radiotracers for colorectal cancer diagnosis","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2026.217971","article-title":"Recent progress in metal-based drugs for colorectal cancer therapy","volume":"562","author":"Liu","year":"2026","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119428_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119428_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/acs.jmedchem.5c02237","article-title":"Targeting class I histone deacetylases triggers antitumor responses in colorectal cancer in vitro and in vivo","volume":"69","author":"Carullo","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib7","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jmedchem.5c03826","article-title":"RSPO2-based peptibodies conjugated with pyrrolobenzodiazepine dimer or camptothecin analogs demonstrate potent antitumor activity by targeting the three receptors LGR4\/5\/6 in colorectal cancer and neuroblastoma","volume":"69","author":"Toh","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib8","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1021\/acs.jmedchem.4c00366","article-title":"Discovery of the next-generation platinum-based anticancer agents for combating oxaliplatin-induced drug resistance","volume":"67","author":"Sun","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib9","doi-asserted-by":"crossref","first-page":"17207","DOI":"10.1021\/acs.jmedchem.4c01098","article-title":"Syntheses of LSD1\/HDAC inhibitors with demonstrated efficacy against colorectal cancer: in vitro and in vivo studies including patient-derived organoids","volume":"67","author":"Chou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib10","doi-asserted-by":"crossref","first-page":"23941","DOI":"10.1021\/acs.jmedchem.5c01321","article-title":"Design and synthesis of novel N-(1H-pyrazol-3-yl)pyrimidin-4-amine aurora\/HDAC dual inhibitors for colorectal cancer treatment","volume":"68","author":"Cui","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib11","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1021\/acs.jmedchem.4c02116","article-title":"Novel indoleamine-2,3-dioxygenase-targeted Pt(IV) prodrugs regulate the tumor immune microenvironment to achieve chemoimmunotherapy in vitro and in vivo","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib12","doi-asserted-by":"crossref","first-page":"24094","DOI":"10.1021\/acs.jmedchem.5c01858","article-title":"Crizotinib- or ceritinib-conjugated platinum(IV) prodrugs as potent multiaction agents inducing antiproliferative effects in 2D and 3D cancer cell models","volume":"68","author":"Sharkawy","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213640","article-title":"Platinum(IV) antitumor complexes and their nano-drug delivery","volume":"429","author":"Jia","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119428_bib14","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1021\/acs.jmedchem.4c00843","article-title":"Canadine platinum(IV) complexes targeting epithelial-mesenchymal transition as antiproliferative and antimetastatic agents","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib15","doi-asserted-by":"crossref","first-page":"24294","DOI":"10.1021\/acs.jmedchem.5c02196","article-title":"Pt(IV) prodrugs bearing sunitinib-derived ligands display exceptional anticancer activity against renal cell carcinoma when compared to conventional platinum chemotherapy","volume":"68","author":"Beirne","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib16","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/acs.jmedchem.4c02909","article-title":"Pt(IV)-PROTAC complexes with synergistic antitumor activity and enhanced membrane permeability","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib17","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1021\/acs.jmedchem.2c01318","article-title":"Pt(IV) prodrug as a potential antitumor agent with APE1 inhibitory activity","volume":"65","author":"Yuan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib18","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1021\/acs.jmedchem.3c00336","article-title":"Multifunctional iridium(III)\u2212platinum(IV) conjugatesas potent anticancer theranostic agents","volume":"66","author":"Gupta","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib19","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acs.jmedchem.2c01660","article-title":"Combination of DNA damage.; autophagy.; and ERK inhibition: novel evodiamine-inspired multi-action Pt(IV) prodrugs with high efficiency and low-toxicity antitumor activity","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib20","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1039\/D2QI01398C","article-title":"Ptxplatin: a multifunctional Pt(IV) antitumor prodrug","volume":"9","author":"Zhang","year":"2022","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ejmech.2026.119428_bib21","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1039\/D3SC01874A","article-title":"Regulating tumor glycometabolism and the immune microenvironment by inhibiting lactate dehydrogenase with platinum(iv) complexes","volume":"14","author":"Jin","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119428_bib22","doi-asserted-by":"crossref","first-page":"11928","DOI":"10.1021\/acs.jmedchem.5c00815","article-title":"Grapefruit extracellular-vesicle-derived nanodrug loading three-functional platinum(IV) conjugates with enhanced targeting and TME modulating properties","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106354","article-title":"Dual-target platinum(IV) complexes reverse cisplatin resistance in triple negative breast via inhibiting poly(ADP-ribose) polymerase (PARP-1) and enhancing DNA damage","volume":"133","author":"Li","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib24","article-title":"Overcoming cancer resistance to platinum drugs by inhibiting cholesterol metabolism","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119428_bib25","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1021\/acs.jmedchem.1c01236","article-title":"Ketoprofen and loxoprofen platinum(IV) complexes displaying antimetastatic activities by inducing DNA damage, inflammation suppression, and enhanced immune response","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216808","article-title":"Recent advances in antitumor Pt(IV) complexes: dual targeting and chemoimmunotherapy","volume":"541","author":"Spector","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119428_bib27","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1021\/acs.jmedchem.3c00269","article-title":"Platinum (IV) derivatives of [Pt(1S,2S-diaminocyclohexane) (5,6-dimethyl-1,10- phenanthroline)] with diclofenac ligands in the axial positions: a new class of potent multi-action agents exhibiting selectivity to cancer cells","volume":"66","author":"Kostrhunova","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111353","article-title":"Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?","volume":"217","author":"Gibson","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119428_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213991","article-title":"Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs","volume":"442","author":"Xu","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119428_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215578","article-title":"Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands","volume":"501","author":"\u0160tarha","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119428_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.119428_bib32","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1021\/acs.jmedchem.1c00579","article-title":"Targeting autophagy-related epigenetic regulators for cancer drug discovery","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216867","article-title":"Autophagy flux in bladder cancer: cell death crosstalk, drug and nanotherapeutics","volume":"591","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119428_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119428_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123184","article-title":"Harnessing prazosin for tumors: liposome hybrid nanovesicles activate tumor immunotherapy via autophagy inhibition","volume":"319","author":"Xuanyuan","year":"2025","journal-title":"Biomater"},{"key":"10.1016\/j.ejmech.2026.119428_bib36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/cas.70305","article-title":"IRF4 enhances radiosensitivity of cervical cancer by inhibiting the PI3K\/Akt\/mTOR pathway to regulate autophagy","volume":"17","author":"Gao","year":"2026","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2026.119428_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109746","article-title":"Synergic effect of PD-1 blockade and endostar on the PI3K\/AKT\/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model","volume":"125","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119428_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2021.112583","article-title":"Nickel induces autophagy via PI3K\/AKT\/mTOR and AMPK pathways in mouse kidney","volume":"223","author":"Yin","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ejmech.2026.119428_bib39","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells10051261","article-title":"PI3K\/mTOR dual inhibitor PF-04691502 is a schedule-dependent radiosensitizer for gastroenteropancreatic neuroendocrine tumors","volume":"10","author":"Chow","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119428_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70153","article-title":"Mechanistic insights into the anticancer potential of echinacoside: therapeutic applications and future directions","volume":"358","author":"Sheokand","year":"2025","journal-title":"Archiv. Der. Pharmazie."},{"key":"10.1016\/j.ejmech.2026.119428_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/pharmaceutics17020246","article-title":"Novel peptide-modified zeolitic imidazolate framework-8 nanoparticles with pH-sensitive release of doxorubicin for targeted treatment of colorectal cancer","volume":"17","author":"Gong","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119428_bib42","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S577058","article-title":"Linoleic acid reduces paclitaxel chemosensitivity in colorectal cancer","volume":"20","author":"Zhou","year":"2026","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.119428_bib43","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1021\/acs.biomac.5c01421","article-title":"Multifunctional polymeric nanoparticles codelivering paclitaxel and monoclonal antibodies for triple combination therapy of colorectal cancer","volume":"26","author":"Zeng","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2026.119428_bib44","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.3390\/ijms27083705","article-title":"Liposomal encapsulation of camptothecin\/carboxymethyl-\u03b2-cyclodextrin complexes: stability, solubility and cytotoxicity","volume":"27","author":"Mes\u00edas-Recam\u00e1n","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119428_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112040","article-title":"Therapeutic potentials of curcumin in the treatment of glioblstoma","volume":"188","author":"Shabaninejad","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib46","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/molecules29091985","article-title":"Design and synthesis of dimethylaminomethyl-substituted curcumin derivatives: potent anti-inflammatory, anti-oxidant, and radioprotection activity, improved aqueous solubility compared with curcumin","volume":"29","author":"Gu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119428_bib47","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2026.119428_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2013.03.014","article-title":"2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage","volume":"707","author":"Zhou","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119428_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112177","article-title":"Diarylpentanoids with antitumor activity: a critical review of structure-activity relationship studies","volume":"192","author":"Moreira","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/mc.22492","article-title":"Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer","volume":"56","author":"Rajitha","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejmech.2026.119428_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2013.08.002","article-title":"Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer","volume":"341","author":"Nagaraju","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119428_bib52","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ejmech.2016.10.027","article-title":"Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer","volume":"125","author":"Wu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib53","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.3390\/cancers15225478","article-title":"Anticarcinogenic potency of EF24: an overview of its pharmacokinetics, efficacy, mechanism of action, and nanoformulation for drug delivery","volume":"15","author":"Sazdova","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119428_bib54","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fonc.2018.00614","article-title":"Bioactivities of EF24, a novel curcumin analog: a review","volume":"8","author":"He","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119428_bib55","article-title":"Multifunctional oral hydrogel containing dual\u2010active Pt\/Mn3 O4 nanozyme for synergistic pyroptosis suppression and gut microenvironment reprogramming to alleviate radiation intestinal injury","volume":"22","author":"Liu","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.ejmech.2026.119428_bib56","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1021\/acs.jmedchem.4c02840","article-title":"Discovery of a novel EF24 analogue-conjugated Pt(IV) complex as multi-target Pt(IV) prodrugs aims to enhance anticancer activity and overcome cisplatin resistance","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib57","doi-asserted-by":"crossref","first-page":"26328","DOI":"10.1021\/acs.jmedchem.5c02436","article-title":"An enhanced cancer immunogenic cell death strategy: fibrate-oxaliplatin(iv) conjugates with modulating tumor immune microenvironment","volume":"68","author":"Liang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202518623","article-title":"A triple threat against ovarian cancer: os(ii)-pt(iv)-ceritinib conjugates for photodynamic therapy, chemotherapy, and immunogenic cell death induction","volume":"64","author":"Redrado","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119428_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add3599","article-title":"Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis","volume":"8","author":"Yu","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119428_bib60","article-title":"Oxaliplatin\/norcantharidin prodrug co-loaded nanoparticles: synergistic DNA-repair blockade plus PD-L1 downregulation for inhibit tumor growth and metastasis","volume":"15","author":"Chen","year":"2026","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejmech.2026.119428_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.172183","article-title":"An engineered Pt(IV) conjugate for synergizing extracellular matrix remodeling with chemoimmunotherapy to reverse anti-PD-L1 resistance","volume":"528","author":"Cui","year":"2026","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejmech.2026.119428_bib62","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1021\/acs.jmedchem.5c00352","article-title":"Fluoxetine-conjugated platinum(IV) prodrugs targeting eEF2K and conquering multidrug resistance against triple-negative breast cancer","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib63","doi-asserted-by":"crossref","first-page":"16748","DOI":"10.1021\/acs.jmedchem.6c00377","article-title":"Development of telmisartan platinum(IV) complexes for antimetastatic therapy: targeting EMT and tumor immunity through suppressing AT1R","volume":"69","author":"Feng","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib64","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.1021\/acs.jmedchem.6c01327","article-title":"Pt(IV) complexes incorporating CDC25A\/NF-\u03baB dual inhibitory 1,4-naphthoquinone derivatives trigger multimodal cell death in A2780 ovarian cancer cells","volume":"69","author":"Huang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib65","doi-asserted-by":"crossref","first-page":"14995","DOI":"10.1021\/acs.jmedchem.5c01170","article-title":"Precision-oriented theophylline-platinum(IV) prodrugs: eliciting synthetic lethality in BRCA1-deficient ovarian cancer with enhanced efficacy and reduced toxicity in vitro and in vivo","volume":"68","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib66","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.jmedchem.4c02509","article-title":"Platinum(IV) complexes trigger death receptors and natural killer cells to suppress breast cancer","volume":"68","author":"Cai","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib67","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1021\/acsnano.4c15456","article-title":"Mitochondrial-targeted multifunctional platinum-based nano \u201cterminal-sensitive projectile\u201d for enhanced cancer chemotherapy efficacy","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119428_bib68","article-title":"CaCO(3)-encircled hollow CuS nanovehicles to suppress cervical cancer through enhanced calcium overload-triggered mitochondria damage","volume":"19","author":"Wang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2026.119428_bib69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12935-021-02137-x","article-title":"Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating annexin A2 and DRP1 protein expression","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.119428_bib70","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/s41467-023-40087-2","article-title":"Structures of P53\/BCL-2 complex suggest a mechanism for P53 to antagonize BCL-2 activity","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119428_bib71","doi-asserted-by":"crossref","first-page":"30053","DOI":"10.1021\/acsnano.4c11455","article-title":"Hollow calcium\/copper bimetallic amplifier for cuproptosis\/paraptosis\/apoptosis cancer therapy via cascade reinforcement of endoplasmic reticulum stress and mitochondrial dysfunction","volume":"18","author":"Xu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119428_bib72","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1021\/acsnano.3c03450","article-title":"A native drug-free macromolecular therapeutic to trigger mutual reinforcing of endoplasmic reticulum stress and mitochondrial dysfunction for cancer treatment","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119428_bib73","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.actbio.2026.04.002","article-title":"Bovine serum albumin-stabilized nano-delivery system potentiates targeted anti-angiogenic therapy and synergistic photo-immunotherapy to restrict lung cancer metastasis","volume":"215","author":"Fu","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejmech.2026.119428_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164968","article-title":"Signaling metabolite succinylacetone activates HIF-1\u03b1 and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma","volume":"8","author":"Luo","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2026.119428_bib75","article-title":"Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers. Drug resist","volume":"73","author":"Li","year":"2024","journal-title":"Update"},{"key":"10.1016\/j.ejmech.2026.119428_bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","article-title":"Targeting autophagy to overcome drug resistance: further developments","volume":"13","author":"Chang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.119428_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114691","article-title":"Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells","volume":"242","author":"Guo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib78","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.1021\/acs.jmedchem.5c03562","article-title":"Antitumor cytisine-platinum(IV) prodrugs potentiate crosstalk between endoplasmic reticulum and mitochondria through calcium overload accompanied by immunogenic cell death","volume":"69","author":"Sang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119428_bib79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12951-025-03091-w","article-title":"Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis","volume":"23","author":"Hao","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2026.119428_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/cancers18020205","article-title":"Autophagy modulates immunogenic cell death in cancer","volume":"18","author":"Matsushita","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119428_bib81","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1021\/acs.jmedchem.5c00883","article-title":"Endoplasmic reticulum-targeting iridium(III) complexes induce pyroptosis and enhance immunogenic cell death in MDA-MB-231 cells","volume":"68","author":"Wu","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:07Z","timestamp":1792599967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":81,"alternative-id":["S0223523426008731"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119428","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor EF24 analogue-integrated platinum (IV) prodrugs induce autophagy-mediated immunogenic cell death and PD-L1 downregulation in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119428"}}